Dung-Tsa Chen
Overview
Explore the profile of Dung-Tsa Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
3082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Permuth J, Park M, Davis E, Alhassan S, Arnoletti J, Basinski T, et al.
Res Sq
. 2025 Feb;
PMID: 39989973
Pancreatic ductal adenocarcinoma is projected to become the second leading cause of cancer-related deaths by 2040, with the highest disease burden expected amongst Non-Hispanic Blacks. One of the most significant...
2.
Ozakinci H, Desai B, Kalos D, Chen D, Henry M, Solanki H, et al.
bioRxiv
. 2025 Jan;
PMID: 39764052
Introduction: Recent advances in the treatment of -mutant non-small cell lung cancer (NSCLC) have led to the development of KRAS inhibitors, such as sotorasib and adagrasib. However, resistance and disease...
3.
Glazar D, Sahebjam S, Yu H, Chen D, Bhandari M, Enderling H
CPT Pharmacometrics Syst Pharmacol
. 2024 Dec;
PMID: 39737733
Patients with recurrent high-grade glioma (rHGG) have a poor prognosis with median progression-free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models....
4.
Park M, Gumpper-Fedus K, Krishna S, Genilo-Delgado M, Brantley S, Hart P, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684873
Intraductal papillary mucinous neoplasms (IPMN) are commonly detected pancreatic cysts that may transform into pancreatic ductal adenocarcinoma (PDAC). Predicting which IPMNs will progress to PDAC remains a clinical challenge. Moreover,...
5.
Lantz A, Gebert R, Li J, Oliveras J, Gordian E, Perez-Morales J, et al.
J Racial Ethn Health Disparities
. 2024 Nov;
PMID: 39543072
Background: Herein, we report the characterization of four cohorts of breast cancer patients including (1) non-Hispanic Whites in Florida, (2) non-Hispanic Blacks in Florida, (3) Hispanics in Florida, and (4)...
6.
Ozakinci H, Song X, Nazario G, Lila T, Chen B, Simpson T, et al.
J Immunol
. 2024 Aug;
213(7):1033-1041.
PMID: 39120462
Immunotherapy response is associated with the presence of conventional dendritic cells (cDCs). cDC type 1 (cDC1) is critically important for CD8+ T cell activation, cDC type 2 (cDC2) regulates CD4+...
7.
Permuth J, Park M, Chen D, Basinski T, Powers B, Gwede C, et al.
Front Oncol
. 2024 Aug;
14:1362244.
PMID: 39109281
Introduction: Cancer-associated cachexia (CC) is a progressive syndrome characterized by unintentional weight loss, muscle atrophy, fatigue, and poor outcomes that affects most patients with pancreatic ductal adenocarcinoma (PDAC). The ability...
8.
Tanvetyanon T, Chen D, Gray J
Clin Lung Cancer
. 2024 Jun;
25(7):e304-e311.
PMID: 38825406
Background: ALK or EGFR inhibitor is an ideal frontline treatment for patients with advanced non-small cell lung cancer (NSCLC) harboring targetable alteration in ALK or EGFR. However, in the real-world...
9.
Jeong D, Morse B, Polk S, Chen D, Li J, Hodul P, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201633
Background: While multiple cyst features are evaluated for stratifying pancreatic intraductal papillary mucinous neoplasms (IPMN), cyst size is an important factor that can influence treatment strategies. When magnetic resonance imaging...
10.
Gilardone S, Thapa R, Laborde J, Shafique M, Saltos A, Creelan B, et al.
J Thorac Dis
. 2023 Dec;
15(11):6115-6125.
PMID: 38090314
Background: The optimal treatment sequencing for patients with metastatic epidermal growth factor receptor ()-mutant non-small cell lung cancer (NSCLC) remains a subject of debate. In the United States, osimertinib is...